Accueil   Diary - News   All news ImmunID Key Technology Patents Covering ImmunTraCkeR® and ImmunIG® Granted in the United States, Europe, Canada and Japan

ImmunID Key Technology Patents Covering ImmunTraCkeR® and ImmunIG® Granted in the United States, Europe, Canada and Japan

ImmunID today announced the granting of key patents in the United States, Europe, Canada and Japan. These patents cover the underlying technology of the ImmunTraCkeR® and ImmunIG® assays, which are evaluating a patient’s own immune system, both T-Cell repertoire and B-Cell repertoire. ImmunTraCkeR® has demonstrated clinical utility predicting response to immuno-oncology therapies and is currently under further validation for prediction of response and monitoring of cancer patients under treatment with immune checkpoint inhibitors

 

Read the press release